Publications

Thromboxane biosynthesis and risk of future events in diabetes mellitus: A sub-study of the ASCEND trial.

PARISH S. et al, (2023), European Heart Journal

Reliability of major bleeding events in UK routine data versus clinical trial adjudicated follow-up data.

Harper C. et al, (2023), Heart

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk None. and RECOVERY Collaborative Group None., (2023), Lancet, 401, 1499 - 1507

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial.

Parish S. et al, (2023), Trials, 24

Data provenance and integrity of health-care systems data for clinical trials.

Murray ML. et al, (2022), Lancet Digit Health, 4, e567 - e568

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.

RECOVERY Collaborative Group None., (2022), Lancet, 400, 359 - 368

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2022), Lancet, 399, 143 - 151

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

RECOVERY Collaborative Group None. et al, (2022)

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

RECOVERY Collaborative Group None. et al, (2022)

Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2021), The Lancet. Respiratory medicine, 9, 1419 - 1426

Performance of the UKPDS Outcomes Model 2 in a contemporary UK type 2 diabetes trial cohort

Keng MJ. et al, (2021), Value in Health

What is the association of COVID-19 with heart attacks and strokes?

Mafham M. and Baigent C., (2021), Lancet, 398, 561 - 563

The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19.

Pessoa-Amorim G. and Mafham MM., (2021), Cardiovasc Res, 117, e110 - e113

Making trials part of good clinical care: lessons from the RECOVERY trial.

Pessoa-Amorim G. et al, (2021), Future Healthc J, 8, e243 - e250

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

RECOVERY Collaborative Group None. et al, (2021)

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

RECOVERY Collaborative Group None. et al, (2021)

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2021), Lancet, 397, 2049 - 2059

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2021), Lancet, 397, 1637 - 1645

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The RECOVERY Collaborative Group None. et al, (2021)

A biomarker-based biological age in UK Biobank: composition and prediction of mortality and hospital admissions.

Chan MS. et al, (2021), J Gerontol A Biol Sci Med Sci

Cookies on this website

Publications